These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22900953)

  • 1. Nitric oxide pathway-related gene alterations in inflammatory bowel disease.
    Gillberg L; Varsanyi M; Sjöström M; Lördal M; Lindholm J; Hellström PM
    Scand J Gastroenterol; 2012 Nov; 47(11):1283-97. PubMed ID: 22900953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the pathogenesis of inflammatory bowel disease: transcription factors analysis in bioptic tissues from pediatric patients.
    Pierdomenico M; Stronati L; Costanzo M; Vitali R; Di Nardo G; Nuti F; Oliva S; Cucchiara S; Negroni A
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):271-9. PubMed ID: 21336161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.
    Costello CM; Mah N; Häsler R; Rosenstiel P; Waetzig GH; Hahn A; Lu T; Gurbuz Y; Nikolaus S; Albrecht M; Hampe J; Lucius R; Klöppel G; Eickhoff H; Lehrach H; Lengauer T; Schreiber S
    PLoS Med; 2005 Aug; 2(8):e199. PubMed ID: 16107186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
    Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
    Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.
    Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M
    J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation.
    McLaughlan JM; Seth R; Vautier G; Robins RA; Scott BB; Hawkey CJ; Jenkins D
    J Pathol; 1997 Jan; 181(1):87-92. PubMed ID: 9072008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
    Autschbach F; Giese T; Gassler N; Sido B; Heuschen G; Heuschen U; Zuna I; Schulz P; Weckauf H; Berger I; Otto HF; Meuer SC
    Virchows Arch; 2002 Nov; 441(5):500-13. PubMed ID: 12447682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible and endothelial nitric oxide synthase genes polymorphism in inflammatory bowel disease.
    Oliver J; Gómez-Garcia M; Vilchez JR; López-Nevot MA; Piñero A; Correro F; Nieto A; Martín J
    Tissue Antigens; 2006 Apr; 67(4):326-30. PubMed ID: 16634870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis.
    Yokoyama K; Mitomi H; Kobayashi K; Katsumata T; Saigenji K; Okayasu I
    Hepatogastroenterology; 2001; 48(38):401-7. PubMed ID: 11379318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
    Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
    Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
    Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
    Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations.
    Planell N; Lozano JJ; Mora-Buch R; Masamunt MC; Jimeno M; Ordás I; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
    Gut; 2013 Jul; 62(7):967-76. PubMed ID: 23135761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome.
    Palmieri O; Mazzoccoli G; Bossa F; Maglietta R; Palumbo O; Ancona N; Corritore G; Latiano T; Martino G; Rubino R; Biscaglia G; Scimeca D; Carella M; Annese V; Andriulli A; Latiano A
    Chronobiol Int; 2015; 32(7):903-16. PubMed ID: 26172092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I; Hasan F; Khan I
    Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.